Table 1.
Clinical characteristics of RNA-seq cohort
Clinical Characteristic | Value (%) |
---|---|
FIGO stage | |
IB1 | 1 (5) |
IB2 | 4 (20) |
IIB | 11 (55) |
IIIB | 4 (20) |
Nodal involvement on PET | |
Pelvic | 10 (50) |
Pelvic and Para-aortic | 1 (5) |
None | 9 (45) |
Histology | |
Squamous | 19 (95) |
Adenocarcinoma | 1 (5) |
HPV type prior to CRT | |
HPV 16 | 11 (55) |
HPV 18 | 3 (15) |
HPV 33 | 1 (5) |
HPV 45 | 1 (5) |
HPV 52 | 1 (5) |
HPV 68 | 1 (5) |
HPV negative | 2 (10) |
Outcome | |
Dead of disease (DOD) | 7 (35) |
No Evidence of Disease (NED) | 13 (65) |